As of January 22, 2025, Poseida Therapeutics (PSTX) has a market cap of $0.93 billion USD. According to our data, Poseida Therapeutics is ranked No.5322 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.93 B |
-1.04%
|
Dec 31, 2024 | $0.94 B |
185.71%
|
Dec 29, 2023 | $0.33 B |
-36.60%
|
Dec 30, 2022 | $0.52 B |
-22.17%
|
Dec 31, 2021 | $0.66 B |
-37.92%
|
Dec 31, 2020 | $1.07 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Market Cap | = | PSTX Stock Price | * | PSTX Shares Outstanding |
= | $9.50 | * | 97.47 M | |
= | $0.93 B |